|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Develops treatment support tools that assist physicians and benefit cancer patients. |
|
| Management |
| Sean McDonald, President and Chief Executive Officer; Sharon Kim, Vice President of Business Development; Mike Gabrin, Chief Information Officer; Holly Gallion, MD, Vice President, Clinical Affairs; Alan Wells, MD, DMSc Chief Scientific Officer |
| |
|
|
| |
|
| Keywords |
| oncology, cancer, advamed |
|
|
|
| Description |
|
Precision Therapeutics is an oncology Services Company dedicated to the individualization of cancer therapy. Precision is a leader in the development and delivery of treatment support tools that assist physicians and benefit cancer patients. |
|
| Products / Services |
Precision?s analysis of the live molecular, proteomic and genomic activity of each patient?s cancer offers an foundation for further development and commercialization of novel predictive markers for cancer therapy.
Precision?s first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual?s malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician with the goal of optimizing patient outcomes.
|
|
| Technology / Differentiation |
| Precision Therapeutics? laboratories are fully equipped to perform tissue culture-based analysis. Our laboratories have been certified to comply with the Centers for Medicare & Medicaid Services CLIA (Clinical Laboratory Improvement Amendments) program, and are licensed by the Pennsylvania Department of Health and the New York State Department of Health. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members